How will the Inflation Reduction Act effect manufacturers of both originator drugs and biosimilars? According to PRECISIONvalue expert Amy Martin, a range of unintended consequences may impact pricing, innovation—and ultimately the therapies available to patients. Watch this short video to see why.
